SOLARA

Solara Active Pharma Sciences Share PriceSolara Active Pharma Sciences

₹332.4
-2 (-0.6%)
As on 09 December, 2023 | 06:43 BSE: 541540 NSE: SOLARAISIN: INE624Z01016

Solara Active Pharma Sciences Performance

Day Range

  • Low 331.50
  • High 338.15
₹ 332.4

52 Week Range

  • Low 286.00
  • High 495.00
₹ 332.4
  • Open Price335.45
  • Previous Close334.40
  • Volume37629

Start SIP in Solara Active Pharma Sciences

Start SIP

Solara Active Pharma Sciences Share Price

  • Over 1 Month -1.22%
  • Over 3 Month -10.05%
  • Over 6 Month -6.25%
  • Over 1 Year -24.85%

Solara Active Pharma Sciences Key Statistics

P/E Ratio -36.8
PEG Ratio -0.5
Market Cap Cr 1,197
Price to Book Ratio 0.8
EPS -6
Dividend 0
Relative Strength Index 47.22
Money Flow Index 46.09
MACD Signal 0.06
Average True Range 9.06

Solara Active Pharma Sciences Investment Rating

  • Master Rating:
  • Solara Active Pharma Scis has an operating revenue of Rs. 1,552.92 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of -3% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Solara Active Pharma Sciences Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 425352381395338330361
Operating Expenses Qtr Cr 388333329349311320348
Operating Profit Qtr Cr 38195245281013
Depreciation Qtr Cr 26262628292828
Interest Qtr Cr 24262224222321
Tax Qtr Cr 0-1020-9-15-33
Net Profit Qtr Cr -15-2060-10-190
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,4661,287
Operating Expenses Annual Cr 1,3101,188
Operating Profit Annual in Cr 13480
Depreciation Cr 111112
Interest Annual Cr 9075
Tax Annual Cr -23-33
Net Profit Annual Cr -22-59
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 156-242
Cash from Investing Activity Annual Cr -81-243
Cash from Financing Annual Activity Cr -113334
Net Cash Flow Annual Cr -38-151
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,5031,527
Fixed Assets Annual Cr 1,5801,573
Total Non Current Assets Annual Cr 1,7041,710
Total Current Assets Annual Cr 1,1911,240
Total Assets Annual Cr 2,8952,950
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 418424
ROE Annual % -1-4
ROCE Annual % 3-1
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 118
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 425352381395338330361
Operating Expenses Qtr Cr 388333332350311318347
Operating Profit Qtr Cr 38194945281314
Depreciation Qtr Cr 26262628292828
Interest Qtr Cr 24252224222321
Tax Qtr Cr 0-1010-9-15-33
Net Profit Qtr Cr -17-2040-10-162
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,4661,288
Operating Expenses Annual Cr 1,3101,188
Operating Profit Annual in Cr 13480
Depreciation Cr 111112
Interest Annual Cr 9075
Tax Annual Cr -23-33
Net Profit Annual Cr -22-58
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 156-242
Cash from Investing Activity Annual Cr -81-243
Cash from Financing Annual Activity Cr -113334
Net Cash Flow Annual Cr -38-151
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,5001,525
Fixed Assets Annual Cr 1,2371,230
Total Non Current Assets Annual Cr 1,7121,713
Total Current Assets Annual Cr 1,1881,239
Total Assets Annual Cr 2,8992,953
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 417424
ROE Annual % -1-4
ROCE Annual % 3-1
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 118

Solara Active Pharma Sciences Technicals

EMA & SMA

Current Price
₹332.4
-2 (-0.6%)
pointer
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • ₹334.71
  • 50 Day
  • ₹338.76
  • 100 Day
  • ₹348.77
  • 200 Day
  • ₹374.66
  • 20 Day
  • ₹336.05
  • 50 Day
  • ₹334.88
  • 100 Day
  • ₹354.80
  • 200 Day
  • ₹361.10

Solara Active Pharma Sciences Resistance and Support

PIVOT
₹334.02
Resistance
First Resistance 336.53
Second Resistance 340.67
Third Resistance 343.18
RSI 47.22
MFI 46.09
MACD Single Line 0.06
MACD -0.16
Support
First Resistance 329.88
Second Resistance 327.37
Third Resistance 323.23

Solara Active Pharma Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 49,323 2,521,392 51.12
Week 156,137 12,085,004 77.4
1 Month 101,161 5,708,539 56.43
6 Month 172,210 7,358,540 42.73

Solara Active Pharma Sciences Result Highlights

Solara Active Pharma Sciences Synopsis

NSE-Medical-Diversified

Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1443.81 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2023. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.
Market Cap 1,197
Sales 1,553
Shares in Float 2.27
No of funds 42
Yield
Book Value 0.8
U/D Vol ratio 1.6
LTDebt / Equity 16
Alpha -0.11
Beta 0.48

Solara Active Pharma Sciences

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 37.19%39.31%40.97%40.4%
Mutual Funds 1.75%1.71%2.21%2.51%
Foreign Portfolio Investors 17.86%18.71%19.3%19.26%
Financial Institutions/ Banks 0.04%
Individual Investors 19.84%18.06%16.23%16.54%
Others 23.32%22.21%21.29%21.29%

Solara Active Pharma Sciences Management

Name Designation
Mr. Poorvank Purohit Managing Director & CEO
Mr. Kartheek Chintalapati Raju Non Executive Director
Mr. Ankur Nand Thadani Non Executive Director
Mr. Arun Kumar Non Executive Director
Mr. R Ramakrishnan Independent Director
Dr. Kausalya Santhanam Independent Director

Solara Active Pharma Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Solara Active Pharma Sciences Corporate Action

Date Purpose Remarks
2023-11-14 Quarterly Results
2023-08-14 Quarterly Results (Revised) per share(50%)Final Dividend
2023-07-05 Right issue of Equity Shares
2023-05-12 Audited Results
2023-01-25 Quarterly Results

Solara Active Pharma Sciences MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 17,029
Aditya Birla Sun Life Mid Cap Fund Growth 4,252
Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth 704
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
Motilal Oswal S&P BSE Healthcare ETF 8

Solara Active Pharma Sciences FAQs

What is Share Price of Solara Active Pharma Sciences ?

Solara Active Pharma Sciences share price is ₹332 As on 09 December, 2023 | 06:29

What is the Market Cap of Solara Active Pharma Sciences ?

The Market Cap of Solara Active Pharma Sciences is ₹1196.5 Cr As on 09 December, 2023 | 06:29

What is the P/E ratio of Solara Active Pharma Sciences ?

The P/E ratio of Solara Active Pharma Sciences is -36.8 As on 09 December, 2023 | 06:29

What is the PB ratio of Solara Active Pharma Sciences ?

The PB ratio of Solara Active Pharma Sciences is 0.8 As on 09 December, 2023 | 06:29

Q2FY23